10 AbbVie business development leaders
Deal leads for oncology, immunology and eye care sit beside international business development, search and evaluation, technology licensing and global alliances titles among these AbbVie business development leaders, with a VP Business Development & Acquisitions the most senior. Nine hold AbbVie roles now, and three have held Abbott roles. Biotechs preparing for a licensing talk, or pharma teams building a search and evaluation group, can match the person to the deal stage.
Professionals to explore
Andrei Cervoneascii
LinkedInExperience: Executive Director, Business Development & Acquisitions · AbbVie
$808 per 30-minute call
Andrei Cervoneascii has been Executive Director, Business Development & Acquisitions at AbbVie since May 2020, based in New York. The role is described as "Responsible for commercial assessments supporting global licensing and acquisitions across the Eye Care / Ophthalmology therapeutic / disease areas." The fit for how AbbVie sizes the commercial case for an eye care deal.
Is this you? Claim your profile and get paid for calls.
Anthony Brazda
LinkedInExperience: Senior Director, Licensing and Acquisitions · AbbVie
$539 per 30-minute call
Senior Director, Licensing and Acquisitions at AbbVie since April 2016, Anthony Brazda was Director, Licensing & Acquisitions (2013-2016) and Senior Manager, Business Development (2013) there. At Abbott the titles were Senior Manager - Business Development (2010-2013) and Product Manager II (2005-2010). A product manager background alongside more than a decade in licensing and acquisitions suits questions on how commercial teams weigh in on deals.
Is this you? Claim your profile and get paid for calls.
Jeremy L. Schieler
LinkedInExperience: Director, Global Alliances · AbbVie
$471 per 30-minute call
Jeremy L. Schieler is Director, Global Alliances at AbbVie since September 2024. Technology Licensing & Collaborations titles at AbbVie run from Senior Manager (2019-2021) and Associate Director (2021-2023) to Director (2023-2024), and Jeremy L. Schieler was also Manager, Non-Clinical Strategic Sourcing (2017-2019). Licensing and sourcing titles alongside a global alliances seat suit questions on managing a partnership once the agreement is in place.
Is this you? Claim your profile and get paid for calls.
Joachim Vogt
LinkedInExperience: Director, Search and Evaluation International · AbbVie
$471 per 30-minute call
Based in Ludwigshafen, Joachim Vogt has been Director, Search and Evaluation International at AbbVie since September 2018. Joachim Vogt was also Director Global Business Development – Early Stage Partnering at Roche (2016-2018), did business development and consulting at biovaluator (2013-2018), and was Head of Business Development, Managing Director at eADMET GmbH (2013-2015) and Senior Manager Business Development at Wilex AG (2011-2013), with experience from early to late stage therapeutics and platform technologies.
Is this you? Claim your profile and get paid for calls.
John FitzGerald
LinkedInExperience: Former Senior Director, Licensing & Acquisitions · AbbVie
$539 per 30-minute call
John FitzGerald held Senior Director, Licensing & Acquisitions at AbbVie in two spells, 2013-2018 and 2020-2025, with Senior Director, Venture Capital (2018-2020) in between. Earlier, John FitzGerald was Senior Director, Licensing & Acquisitions at Abbott (2001-2012) and worked in International Marketing & Finance at Abbott (1992-2001). The venture capital title makes John FitzGerald the person for questions on how a corporate venture arm and the deal team work together.
Is this you? Claim your profile and get paid for calls.
Michelle Parks
LinkedInExperience: Head, Technology Licensing & Collaborations · AbbVie
$673 per 30-minute call
Michelle Parks, J.D. has held Head, Technology Licensing & Collaborations at AbbVie since June 2014 and Head, Business Partnering - R&D Procurement since August 2025. Michelle Parks was also Head, Clinical Services and Category Management (2021-2025) and Director, Technology Licensing Licensing & Acquisitions (2013-2014), and worked in Business Development at Abbott (2000-2012). The pick for technology licensing and R&D collaboration questions.
Is this you? Claim your profile and get paid for calls.
Rachel Zimet Strick
LinkedInExperience: VP Business Development & Acquisitions Immunology, Specialty, Eye Care and Platforms · AbbVie
$1,346 per 30-minute call
VP Business Development & Acquisitions Immunology, Specialty, Eye Care and Platforms at AbbVie since July 2024, Rachel Zimet Strick describes "Leadership of global business development deals across a wide variety of deal structures." Rachel Zimet Strick was also Head of Immunology Business Development & Acquisitions (2022-2024), Senior Director, Business Development & Acquisitions (2019-2022), Director, Licensing & Acquisitions (2016-2019) and Director, AbbVie Transition Office (2013-2015).
Is this you? Claim your profile and get paid for calls.
Rahul Jerath
LinkedInExperience: Senior Director, Head of Oncology Business Development & Acquisitions · AbbVie
$808 per 30-minute call
Rahul Jerath is Senior Director, Head of Oncology Business Development & Acquisitions at AbbVie since October 2016. Rahul Jerath was also Senior Director, Business Development and Licensing Mergers and Acquisitions at Baxalta (2015-2016), Director (2012-2015) and Senior Manager (2007-2012), Business Development at Baxter International Inc., and Senior Analyst, Business and Investment Analysis at Takeda (2004-2007); their LinkedIn profile cites target selection, diligence, valuation and negotiations.
Is this you? Claim your profile and get paid for calls.
Sridhar Gopal
LinkedInExperience: Head Of International Business Development · AbbVie
$1,010 per 30-minute call
Head Of International Business Development at AbbVie since April 2020, Sridhar Gopal describes the role as "Head M&A , Licensing (In/ Out) and Business Development for International for AbbVie." Other titles were Head Of Business Development - International Japan Emerging Markets & Australia (2016-2020), Business Development & New Product Planning Director - JPAC (2013-2016), and at AstraZeneca Senior Transaction Director - Corporate BD (2011-2013) and Regional Business Development Director - Asia Pac (2007-2011).
Is this you? Claim your profile and get paid for calls.
Zohaib Saeed
LinkedInExperience: Director II, Business Development and Acquisitions · AbbVie
$471 per 30-minute call
Zohaib Saeed has been Director II, Business Development and Acquisitions at AbbVie since April 2025, after Director of Acquisitions, Global Business Development - Oncology, CNS, and IDV at Johnson & Johnson (2022-2025). Zohaib Saeed was also Associate Director of Business Development Transactions - Oncology at Bristol Myers Squibb (2019-2022) and held two Celgene titles, including Associate Director of Business Development Search and Evaluation & Strategy (2017-2019). Useful for comparing deal teams at AbbVie, Johnson & Johnson, Bristol Myers Squibb and Celgene.
Is this you? Claim your profile and get paid for calls.
Choose the right perspective
For a therapeutic-area deal, go to Rahul Jerath for oncology, Rachel Zimet Strick for immunology and eye care, or Andrei Cervoneascii for eye care commercial assessments. International deals fit Sridhar Gopal and Joachim Vogt, technology licensing Michelle Parks, alliance management Jeremy L. Schieler, and venture questions John FitzGerald.
Questions to take into the conversation
- 01What does a biotech need to show AbbVie's search and evaluation team before a licensing conversation moves forward?
- 02How is a commercial assessment built for an eye care or immunology licensing target?
- 03How does alliance management keep a co-development partnership on track after the deal is signed?
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.